BNIGFBeroni Group Ltd.

About Beroni Group Ltd. (BNIGF)

Beroni Group Ltd. (BNIGF) is a Conglomerates company headquartered in Sydney, NSW, Australia whose shares trade over-the-counter on the OTCQB tier.

Beroni Group is an international biopharmaceutical enterprise dedicated to the innovation and commercialization of drugs and therapies to combat various global diseases such as cancer and infectious diseases. Its diversified portfolio is comprised of FDA/CE approved virus diagnostic kits, an e-commerce platform for the sale of pharmaceutical products and a development pipeline targeting oncology and cell therapies. Beroni has operations in Australia, United States, China and Japan.

Products and services

Beroni Group is an international biopharmaceutical enterprise dedicated to the innovation and commercialization of drugs and therapies to combat various global diseases such as cancer and infectious diseases. Its diversified portfolio is comprised of FDA/CE approved virus diagnostic kits, an e-commerce platform for the sale of pharmaceutical products and a development pipeline targeting oncology and cell therapies. Beroni has operations in Australia, United States, China and Japan.

BNIGF key facts

Ticker symbol

BNIGF

Market tier

OTCQB

Sector

Industrials

Industry

Conglomerates

Headquarters

Sydney, NSW, Australia

Country of incorporation

AU

Year of incorporation

2016

Employees

60

Estimated market cap

$291.7K (as of May 9, 2025)

Shares outstanding

28,877,282

Reporting standard

International Reporting: National Stock Exchange of Australia

Audit status

Audited

Fiscal year end

12/31

Latest filing

Annual Report (Dec 31, 2024)

Beroni Group Ltd. leadership

• Boqing Zhang — CEO
• Peter Wong — CFO
• Nicholas Ong — Company Secretary

Explore more: Conglomerates stocks · Industrials sector · OTCQB stocks · OTC stocks starting with B